• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

静脉溶栓治疗急性缺血性卒中时的脑小血管病与梗死灶扩大

Cerebral Small Vessel Disease and Infarct Growth in Acute Ischemic Stroke Treated with Intravenous Thrombolysis.

作者信息

Arba Francesco, Ferretti Simone, Leigh Richard, Fara Andreia, Warach Steven J, Luby Marie, Lees Kennedy R, Dawson Jesse

机构信息

Stroke Unit, Careggi University Hospital, Florence, Italy.

NEUROFARBA Department, University of Florence, Careggi University Hospital, Florence, Italy.

出版信息

Transl Stroke Res. 2025 Jun;16(3):925-932. doi: 10.1007/s12975-024-01277-2. Epub 2024 Jul 4.

DOI:10.1007/s12975-024-01277-2
PMID:38963535
Abstract

We investigated relations between cerebral small vessel disease (cSVD) markers and evolution of the ischemic tissue from ischemic core to final infarct in people with acute ischemic stroke treated with intravenous thrombolysis. Data from the Stroke Imaging Repository (STIR) and Virtual International Stroke Trials Archive (VISTA) were used. Any pre-existing lacunar infarcts and white matter hyperintensities (WMH) were assessed on magnetic resonance (MR) before thrombolytic therapy. Acute ischemic core and final infarct volume were then assessed by two independent radiologists. The relationship among baseline markers of cSVD, acute ischemic core volume, final infarct volume, infarct growth (IG = final infarct - ischemic core), and infarct growth ratio (IGR = final infarct/ischemic core) was then assessed using linear and ordinal regression adjusted for age, sex, onset-to-treatment time, and stroke severity. We included 165 patients, mean (± SD) age 69.5 (± 15.7) years, 74 (45%) males, mean (± SD) ischemic core volume 25.48 (± 42.22) ml, final infarct volume 52.06 (± 72.88) ml, IG 26.58 (± 51.02) ml, IGR 8.23 (± 38.12). Seventy (42%) patients had large vessel occlusion, 20 (12%) acute small subcortical infarct. WMHs were present in 131 (79%) and lacunar infarcts in 61 (37%) patients. Final infarct volumes were 53.8 ml and 45.2 ml (WMHs/no WMHs), p = 0.139, and 24.6 ml and 25.9 ml (lacunar infarcts/no lacunar infarcts), p = 0.842. In linear and ordinal regression analyses, presence of lacunar infarcts was associated with smaller IG (β =  - 0.17; p = 0.024; cOR = 0.52; 95%CI = 0.28-0.96, respectively) and WMHs were associated with smaller IGR (β =  - 0.30; p = 0.004; cOR = 0.27; 95%CI = 0.11-0.69, respectively). In people with acute ischemic stroke treated with intravenous thrombolysis, cSVD features were associated with smaller growth of the acute ischemic area, suggesting less salvageable tissue at time of reperfusion therapy.

摘要

我们研究了接受静脉溶栓治疗的急性缺血性脑卒中患者脑小血管病(cSVD)标志物与缺血组织从缺血核心到最终梗死灶演变之间的关系。使用了来自卒中影像数据库(STIR)和虚拟国际卒中试验档案库(VISTA)的数据。在溶栓治疗前通过磁共振(MR)评估任何既往存在的腔隙性梗死和白质高信号(WMH)。然后由两名独立的放射科医生评估急性缺血核心和最终梗死灶体积。接着使用针对年龄、性别、发病至治疗时间和卒中严重程度进行调整的线性回归和有序回归,评估cSVD的基线标志物、急性缺血核心体积、最终梗死灶体积、梗死灶生长(IG = 最终梗死灶 - 缺血核心)和梗死灶生长率(IGR = 最终梗死灶/缺血核心)之间的关系。我们纳入了165例患者,平均(±标准差)年龄69.5(±15.7)岁,74例(45%)为男性,平均(±标准差)缺血核心体积25.48(±42.22)ml,最终梗死灶体积52.06(±72.88)ml,IG为26.58(±51.02)ml,IGR为8.23(±38.12)。70例(42%)患者存在大血管闭塞,20例(12%)为急性小皮质下梗死。131例(79%)患者存在WMH,61例(37%)患者存在腔隙性梗死。最终梗死灶体积在有/无WMH患者中分别为53.8 ml和45.2 ml,p = 0.139,在有/无腔隙性梗死患者中分别为24.6 ml和25.9 ml,p = 0.842。在线性回归和有序回归分析中,腔隙性梗死的存在与较小的IG相关(β = -0.17;p = 0.024;cOR = 0.52;95%CI分别为0.28 - 0.96),WMH与较小的IGR相关(β = -0.30;p = 0.004;cOR = 0.27;95%CI分别为0.11 - 0.69)。在接受静脉溶栓治疗的急性缺血性脑卒中患者中,cSVD特征与急性缺血区域较小的生长相关,提示再灌注治疗时可挽救的组织较少。

相似文献

1
Cerebral Small Vessel Disease and Infarct Growth in Acute Ischemic Stroke Treated with Intravenous Thrombolysis.静脉溶栓治疗急性缺血性卒中时的脑小血管病与梗死灶扩大
Transl Stroke Res. 2025 Jun;16(3):925-932. doi: 10.1007/s12975-024-01277-2. Epub 2024 Jul 4.
2
Impact of Small Vessel Disease on Patient Outcomes After Intravenous Thrombolysis for Acute Ischemic Stroke.小血管疾病对急性缺血性卒中静脉溶栓后患者预后的影响。
Am J Cardiol. 2025 Apr 1;240:76-81. doi: 10.1016/j.amjcard.2024.10.034. Epub 2024 Dec 20.
3
Thrombolysis in acute stroke patients with cerebral small vessel disease.脑小血管病急性卒中患者的溶栓治疗
Cerebrovasc Dis. 2014;37(1):5-13. doi: 10.1159/000356796. Epub 2013 Dec 17.
4
Safety and Efficacy of Intravenous Thrombolysis by Infarct Type in Patients with No Visible Occlusion: A Secondary Analysis of the AcT Trial.无可见血管闭塞患者中静脉溶栓按梗死类型的安全性和有效性:AcT试验的二次分析
J Am Heart Assoc. 2025 Jan 7;14(1):e037577. doi: 10.1161/JAHA.124.037577. Epub 2024 Dec 20.
5
Monitoring intravenous recombinant tissue plasminogen activator thrombolysis for acute ischemic stroke with diffusion and perfusion MRI.使用扩散加权成像和灌注加权成像监测静脉注射重组组织型纤溶酶原激活剂治疗急性缺血性卒中的溶栓过程。
Stroke. 2000 Jun;31(6):1318-28. doi: 10.1161/01.str.31.6.1318.
6
The global burden of cerebral small vessel disease related to neurological deficit severity and clinical outcomes of acute ischemic stroke after IV rt-PA treatment.全球范围内,与神经功能缺损严重程度和 IV 溶栓后急性缺血性卒中临床结局相关的脑小血管病负担。
Neurol Sci. 2019 Jun;40(6):1157-1166. doi: 10.1007/s10072-019-03790-x. Epub 2019 Mar 4.
7
Intravenous Thrombolysis in Patients With White Matter Hyperintensities in the WAKE-UP Trial.WAKE-UP 试验中存在脑白质高信号的患者的静脉溶栓治疗。
Stroke. 2023 Jul;54(7):1718-1725. doi: 10.1161/STROKEAHA.122.040247. Epub 2023 May 25.
8
Clinical Characteristics and Outcome of Patients with Lacunar Infarcts and Concurrent Embolic Ischemic Lesions.腔隙性梗死合并栓塞性缺血病变患者的临床特征和转归。
Clin Neuroradiol. 2020 Sep;30(3):511-516. doi: 10.1007/s00062-019-00800-5. Epub 2019 Jun 3.
9
Outcome of intravenous thrombolysis in acute ischemic stroke patients with small vessel disease.小血管病患者急性缺血性脑卒中静脉溶栓治疗的结局。
Clin Neurol Neurosurg. 2024 Nov;246:108570. doi: 10.1016/j.clineuro.2024.108570. Epub 2024 Oct 1.
10
Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.急性缺血性脑卒中动脉内脑溶栓的试验设计与报告标准。
Stroke. 2003 Aug;34(8):e109-37. doi: 10.1161/01.STR.0000082721.62796.09. Epub 2003 Jul 17.

引用本文的文献

1
Cerebral small vessel disease does not impair leptomeningeal collateral supply in large-vessel occlusion - Results from quantitative collateral mapping with MRI.脑小血管病不会损害大血管闭塞时的软脑膜侧支供血——MRI定量侧支血管造影结果
J Cereb Blood Flow Metab. 2025 Jul 28:271678X251358972. doi: 10.1177/0271678X251358972.
2
Interaction between post-tumor inflammation and vascular smooth muscle cell dysfunction in sepsis-induced cardiomyopathy.脓毒症诱导性心肌病中肿瘤后炎症与血管平滑肌细胞功能障碍之间的相互作用。
Front Immunol. 2025 Apr 10;16:1560717. doi: 10.3389/fimmu.2025.1560717. eCollection 2025.

本文引用的文献

1
Brush sign and collateral supply as potential markers of large infarct growth after successful thrombectomy.血管再通后刷状征和侧支循环作为大梗死体积进展的潜在标志物。
Eur Radiol. 2023 Jun;33(6):4502-4509. doi: 10.1007/s00330-022-09387-x. Epub 2023 Jan 12.
2
Collateral Status and Outcomes after Thrombectomy.取栓术后侧支循环状态与结局。
Transl Stroke Res. 2023 Feb;14(1):22-37. doi: 10.1007/s12975-022-01046-z. Epub 2022 Jun 10.
3
Collateral Recruitment Is Impaired by Cerebral Small Vessel Disease.脑小血管病损害侧支循环募集。
Stroke. 2020 May;51(5):1404-1410. doi: 10.1161/STROKEAHA.119.027661. Epub 2020 Apr 6.
4
White matter hyperintensity burden in patients with ischemic stroke treated with thrombectomy.取栓治疗的缺血性脑卒中患者的脑白质高信号负荷。
Neurology. 2019 Oct 15;93(16):e1498-e1506. doi: 10.1212/WNL.0000000000008317. Epub 2019 Sep 13.
5
Small vessel disease and clinical outcomes after endovascular treatment in acute ischemic stroke.小血管病与急性缺血性脑卒中血管内治疗后的临床结局。
Neurol Sci. 2019 Jun;40(6):1227-1235. doi: 10.1007/s10072-019-03824-4. Epub 2019 Mar 14.
6
Fast Versus Slow Progressors of Infarct Growth in Large Vessel Occlusion Stroke: Clinical and Research Implications.大血管闭塞性卒中梗死灶生长的快速进展者与缓慢进展者:临床及研究意义
Stroke. 2017 Sep;48(9):2621-2627. doi: 10.1161/STROKEAHA.117.017673. Epub 2017 Aug 9.
7
Cerebral White Matter Hypoperfusion Increases with Small-Vessel Disease Burden. Data From the Third International Stroke Trial.脑白质灌注不足随小血管疾病负担增加而加重。来自第三次国际中风试验的数据。
J Stroke Cerebrovasc Dis. 2017 Jul;26(7):1506-1513. doi: 10.1016/j.jstrokecerebrovasdis.2017.03.002. Epub 2017 Mar 15.
8
Small vessel disease and clinical outcomes after IV rt-PA treatment.静脉注射重组组织型纤溶酶原激活剂治疗后的小血管疾病与临床结局
Acta Neurol Scand. 2017 Jul;136(1):72-77. doi: 10.1111/ane.12745. Epub 2017 Feb 23.
9
Leukoaraiosis, intracerebral hemorrhage, and functional outcome after acute stroke thrombolysis.急性卒中溶栓后的白质疏松、脑出血与功能结局
Neurology. 2017 Feb 14;88(7):638-645. doi: 10.1212/WNL.0000000000003605. Epub 2017 Jan 27.
10
Incidence and Predictors of Early Recanalization After Intravenous Thrombolysis: A Systematic Review and Meta-Analysis.静脉溶栓后早期再通的发生率及预测因素:一项系统评价和Meta分析
Stroke. 2016 Sep;47(9):2409-12. doi: 10.1161/STROKEAHA.116.014181. Epub 2016 Jul 26.